The global Lung Cancer Liquid Biopsy market was valued at US$ 425.7 million in 2023 and is anticipated to reach US$ 1082 million by 2030, witnessing a CAGR of 14.0% during the forecast period 2024-2030.

Lung Cancer Liquid Biopsy Market

Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.

CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Liquid Biopsy.

Report Scope

The Lung Cancer Liquid Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Liquid Biopsy Market Report

Report Metric	Details
Report Name	Lung Cancer Liquid Biopsy Market
Accounted market size in 2023	US$ 425.7 million
Forecasted market size in 2030	US$ 1082 million
CAGR	14.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	CTCs CtDNA Exosomes And RNA Others
Segment by Application	Clinics Hospitals Physicians' Office Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, Qiagen, Accuragen, Agena Bioscience, Bard1, Bgi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Liquid Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Liquid Biopsy Market growing?

Ans: The Lung Cancer Liquid Biopsy Market witnessing a CAGR of 14.0% during the forecast period 2024-2030.

What is the Lung Cancer Liquid Biopsy Market size in 2030?

Ans: The Lung Cancer Liquid Biopsy Market size in 2030 will be US$ 1082 million.

Who are the main players in the Lung Cancer Liquid Biopsy Market report?

Ans: The main players in the Lung Cancer Liquid Biopsy Market are Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, Qiagen, Accuragen, Agena Bioscience, Bard1, Bgi

What are the Application segmentation covered in the Lung Cancer Liquid Biopsy Market report?

Ans: The Applications covered in the Lung Cancer Liquid Biopsy Market report are Clinics, Hospitals, Physicians' Office Laboratories

What are the Type segmentation covered in the Lung Cancer Liquid Biopsy Market report?

Ans: The Types covered in the Lung Cancer Liquid Biopsy Market report are CTCs, CtDNA, Exosomes And RNA, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CTCs

1.2.3 CtDNA

1.2.4 Exosomes And RNA

1.2.5 Others

1.3 Market by Application

1.3.1 Global Lung Cancer Liquid Biopsy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Physicians' Office Laboratories

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2019-2030)

2.2 Lung Cancer Liquid Biopsy Growth Trends by Region

2.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Lung Cancer Liquid Biopsy Historic Market Size by Region (2019-2024)

2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2025-2030)

2.3 Lung Cancer Liquid Biopsy Market Dynamics

2.3.1 Lung Cancer Liquid Biopsy Industry Trends

2.3.2 Lung Cancer Liquid Biopsy Market Drivers

2.3.3 Lung Cancer Liquid Biopsy Market Challenges

2.3.4 Lung Cancer Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue

3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2019-2024)

3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2019-2024)

3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue

3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio

3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2023

3.5 Lung Cancer Liquid Biopsy Key Players Head office and Area Served

3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service

3.7 Date of Enter into Lung Cancer Liquid Biopsy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biopsy Breakdown Data by Type

4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2019-2024)

4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2025-2030)

5 Lung Cancer Liquid Biopsy Breakdown Data by Application

5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2019-2024)

5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Lung Cancer Liquid Biopsy Market Size (2019-2030)

6.2 North America Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Lung Cancer Liquid Biopsy Market Size by Country (2019-2024)

6.4 North America Lung Cancer Liquid Biopsy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Liquid Biopsy Market Size (2019-2030)

7.2 Europe Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country (2019-2024)

7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2019-2030)

8.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2019-2024)

8.4 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Liquid Biopsy Market Size (2019-2030)

9.2 Latin America Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2019-2024)

9.4 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2019-2030)

10.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2019-2024)

10.4 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biocept

11.1.1 Biocept Company Detail

11.1.2 Biocept Business Overview

11.1.3 Biocept Lung Cancer Liquid Biopsy Introduction

11.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.1.5 Biocept Recent Development

11.2 Exosome Diagnostics

11.2.1 Exosome Diagnostics Company Detail

11.2.2 Exosome Diagnostics Business Overview

11.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction

11.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.2.5 Exosome Diagnostics Recent Development

11.3 F. Hoffmann-La Roche

11.3.1 F. Hoffmann-La Roche Company Detail

11.3.2 F. Hoffmann-La Roche Business Overview

11.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction

11.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.3.5 F. Hoffmann-La Roche Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Detail

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction

11.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.4.5 Qiagen Recent Development

11.5 Accuragen

11.5.1 Accuragen Company Detail

11.5.2 Accuragen Business Overview

11.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction

11.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.5.5 Accuragen Recent Development

11.6 Agena Bioscience

11.6.1 Agena Bioscience Company Detail

11.6.2 Agena Bioscience Business Overview

11.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction

11.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.6.5 Agena Bioscience Recent Development

11.7 Bard1

11.7.1 Bard1 Company Detail

11.7.2 Bard1 Business Overview

11.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction

11.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.7.5 Bard1 Recent Development

11.8 Bgi

11.8.1 Bgi Company Detail

11.8.2 Bgi Business Overview

11.8.3 Bgi Lung Cancer Liquid Biopsy Introduction

11.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2019-2024)

11.8.5 Bgi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CTCs

Table 3. Key Players of CtDNA

Table 4. Key Players of Exosomes And RNA

Table 5. Key Players of Others

Table 6. Global Lung Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Lung Cancer Liquid Biopsy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Lung Cancer Liquid Biopsy Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Lung Cancer Liquid Biopsy Market Share by Region (2019-2024)

Table 10. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Lung Cancer Liquid Biopsy Market Share by Region (2025-2030)

Table 12. Lung Cancer Liquid Biopsy Market Trends

Table 13. Lung Cancer Liquid Biopsy Market Drivers

Table 14. Lung Cancer Liquid Biopsy Market Challenges

Table 15. Lung Cancer Liquid Biopsy Market Restraints

Table 16. Global Lung Cancer Liquid Biopsy Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Lung Cancer Liquid Biopsy Market Share by Players (2019-2024)

Table 18. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)

Table 19. Ranking of Global Top Lung Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Lung Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Lung Cancer Liquid Biopsy Product Solution and Service

Table 23. Date of Enter into Lung Cancer Liquid Biopsy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2019-2024)

Table 27. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2025-2030)

Table 29. Global Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2019-2024)

Table 31. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2025-2030)

Table 33. North America Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 48. Biocept Company Detail

Table 49. Biocept Business Overview

Table 50. Biocept Lung Cancer Liquid Biopsy Product

Table 51. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 52. Biocept Recent Development

Table 53. Exosome Diagnostics Company Detail

Table 54. Exosome Diagnostics Business Overview

Table 55. Exosome Diagnostics Lung Cancer Liquid Biopsy Product

Table 56. Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 57. Exosome Diagnostics Recent Development

Table 58. F. Hoffmann-La Roche Company Detail

Table 59. F. Hoffmann-La Roche Business Overview

Table 60. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product

Table 61. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 62. F. Hoffmann-La Roche Recent Development

Table 63. Qiagen Company Detail

Table 64. Qiagen Business Overview

Table 65. Qiagen Lung Cancer Liquid Biopsy Product

Table 66. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 67. Qiagen Recent Development

Table 68. Accuragen Company Detail

Table 69. Accuragen Business Overview

Table 70. Accuragen Lung Cancer Liquid Biopsy Product

Table 71. Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 72. Accuragen Recent Development

Table 73. Agena Bioscience Company Detail

Table 74. Agena Bioscience Business Overview

Table 75. Agena Bioscience Lung Cancer Liquid Biopsy Product

Table 76. Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 77. Agena Bioscience Recent Development

Table 78. Bard1 Company Detail

Table 79. Bard1 Business Overview

Table 80. Bard1 Lung Cancer Liquid Biopsy Product

Table 81. Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 82. Bard1 Recent Development

Table 83. Bgi Company Detail

Table 84. Bgi Business Overview

Table 85. Bgi Lung Cancer Liquid Biopsy Product

Table 86. Bgi Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)

Table 87. Bgi Recent Development

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lung Cancer Liquid Biopsy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Lung Cancer Liquid Biopsy Market Share by Type: 2023 VS 2030

Figure 3. CTCs Features

Figure 4. CtDNA Features

Figure 5. Exosomes And RNA Features

Figure 6. Others Features

Figure 7. Global Lung Cancer Liquid Biopsy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Lung Cancer Liquid Biopsy Market Share by Application: 2023 VS 2030

Figure 9. Clinics Case Studies

Figure 10. Hospitals Case Studies

Figure 11. Physicians' Office Laboratories Case Studies

Figure 12. Lung Cancer Liquid Biopsy Report Years Considered

Figure 13. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Lung Cancer Liquid Biopsy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Lung Cancer Liquid Biopsy Market Share by Region: 2023 VS 2030

Figure 16. Global Lung Cancer Liquid Biopsy Market Share by Players in 2023

Figure 17. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2023

Figure 19. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)

Figure 21. United States Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)

Figure 25. Germany Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Region (2019-2030)

Figure 33. China Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)

Figure 41. Mexico Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)

Figure 45. Turkey Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 48. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 50. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 51. Accuragen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 52. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 53. Bard1 Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 54. Bgi Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions